Sketchy Preclinical Checklist micro pharm path bio 2021 PDF

Preview

Summary

Sketchy Preclinical Checklist microbiology pharmacology pathology biochemistry 2021...

Description

SKETCHY MICRO

I.

Bacteria

CHAPTER 1 GRAM POSITIVE COCCI

□ □ □ □ □ □

1.1 - Staphylococcus aureus 1.2 - Staphylococcus epidermidis & saprophyticus 1.3 - Streptococcus pyogenes (group A strep) 1.4 - Streptococcus agalactiae (group B strep) 1.5 - Streptococcus pneumoniae & viridans 1.6 - Enterococcus faecium & faecalis

CHAPTER 2 GRAM POSITIVE BACILLI

□ □ □ □ □ □ □

2.1 - Bacillus anthracis & cereus 2.2 - Clostridium tetani 2.3 - Clostridium botulinum 2.5 - Clostridioides Difficile 2.5 - Clostridium perfringens 2.6 - Corynebacterium diphtheriae 2.7 - Listeria monocytogenes

CHAPTER 3 GRAM-POSITIVE BRANCHING FILAMENTOUS RODS

□ 3.1 - Actinomyces israelii □ 3.2 - Nocardia asteroides CHAPTER 4 GRAM-NEGATIVE COCCI

□ 4.1 - Neisseria overview □ 4.2 - Neisseria meningitidis □ 4.3 - Neisseria gonorrhoeae CHAPTER 5 GRAM-NEGATIVE BACILLI - ENTERIC TRACT

□ □ □ □ □ □ □ □ □

5.1 - Klebsiella pneumoniae, Enterobacter spp., Serratia marcescens 5.2 - Salmonella enteritidis & typhi 5.3 - Shigella spp. 5.4 - Escherichia coli (ETEC, EHEC) 5.5 - Yersinia enterocolitica & pestis 5.6 - Campylobacter jejuni 5.7 - Vibrio spp. 5.8 - Helicobacter pylori 5.9 - Proteus mirabilis

Page 1 of 5

SKETCHY MICRO CHAPTER 6 GRAM-NEGATIVE BACILLI - RESPIRATORY TRACT

□ □ □ □

6.1 - Bordetella pertussis 6.2 - Haemophilus influenzae 6.3 - Legionella pneumophila 6.4 - Pseudomonas aeruginosa

CHAPTER 7 GRAM-NEGATIVE BACILLI - ZOONOTICS

□ □ □ □

7.1 - Bartonella henselae 7.2 - Brucella spp. 7.3 - Francisella tularensis 7.4 - Pasteurella multocida

CHAPTER 8 MYCOBACTERIA

□ 8.1 - Mycobacterium tuberculosis □ 8.2 - Mycobacterium leprae CHAPTER 9 SPIROCHETES

□ 9.1 - Borrelia burgdorferi □ 9.2 - Leptospira interrogans □ 9.3 - Treponema pallidum CHAPTER 10 GRAM-INDETERMINATE BACTERIA

□ □ □ □ □ □ □

II.

10.1 - Chlamydia trachomatis, Chlamydophila pneumoniae & Chlamydophila psittaci 10.2 - Coxiella burnetii 10.3 - Gardnerella vaginalis 10.4 - Mycoplasma pneumoniae 10.5 - Rickettsia overview 10.6 - Rickettsia prowazekii 10.7 - Rickettsia rickettsia

Viruses

CHAPTER 1 RNA VIRUSES - POSITIVE SENSE

□ □ □ □ □

1.1 - Picornaviridae overview 1.2 - Poliovirus (Picornaviridae) 1.3 - Coxsackievirus A & B (Picornaviridae) 1.4 - Rhinovirus (Picornaviridae) 1.5 - Hepatitis A virus (Picornaviridae) Page 2 of 5

SKETCHY MICRO

□ □ □ □ □ □ □

1. 6- Norovirus/Norwalk virus (Caliciviridae) 1.7 - Flaviviridae overview 1.8 - Hepatitis C virus (Flaviviridae) 1.9 - Eastern/Western/Venezuelan equine encephalitis virus, Rubella virus (Togaviridae) 1.10 - Coronavirus (Coronaviridae) 1.11 - HIV Part 1: Overview (Retroviridae) 1.12 - HIV Part 2: Life Cycle

CHAPTER 2 RNA VIRUSES - NEGATIVE SENSE

□ 2.1 - Influenzavirus (Orthomyxoviridae) □ 2.2 - Measles virus, mumps virus, respiratory syncytial virus, parainfluenza virus (Paramyxoviridae) □ 2.3 - Rabies virus (Rhabdoviridae) □ 2.4 - Ebolavirus, Marburgvirus (Filoviridae) □ 2.5 - Hantavirus, California encephalitis virus, Rift Valley fever virus (Bunyaviridae) □ 2.6 - Lymphocytic choriomeningitis virus (Arenaviridae) □ 2.7 - Rotavirus, Colorado tick fever virus (Reoviridae) CHAPTER 3 DNA VIRUSES

□ □ □ □ □ □ □ □ □ □ □ □

3.1 - Herpes simplex virus type 1 & 2 (Herpesviridae) 3.2 - Epstein–Barr virus (Herpesviridae) 3.3 - Cytomegalovirus (Herpesviridae) 3.4 - Varicella-zoster virus (Herpesviridae) 3.5 - HHV-6, roseola (Herpesviridae) 3.6 - HHV-8, Kaposi's sarcoma (Herpesviridae) 3.7 - JC polyomavirus, BK polyomavirus (Polyomaviridae) 3.8 - Human papillomavirus (Papillomaviridae) 3.9 - Parvovirus B19 (Parvoviridae) 3.10 - Adenovirus (Adenoviridae) 3.11 - Smallpox virus, Cowpox virus, Molluscum contagiosum virus (Poxviridae) 3.12 - Hepatitis B virus (Hepadnaviridae)

III. Fungi CHAPTER 1 SYSTEMIC MYCOSES

□ 1.1 - Histoplasma capsulatum □ 1.2 - Blastomyces dermatitidis Page 3 of 5

SKETCHY MICRO

□ 1.3 - Coccidioides immitis □ 1.4 - Paracoccidioides brasiliensis CHAPTER 2 CUTANEOUS MYCOSES

□ 2.1 - Malassezia furfur □ 2.2 - Epidermophyton spp., Trichophyton spp., Microsporum spp. (dermatophytes) □ 2.3 - Sporothrix schenckii CHAPTER 3 OPPORTUNISTIC FUNGAL INFECTIONS

□ □ □ □ □

3.1 - Candida albicans 3.2 - Aspergillus fumigatus 3.3 - Cryptococcus neoformans 3.4 - Mucor spp., Rhizopus spp. (mucormycetes) 3.5 - Pneumocystis jirovecii

IV. Parasites CHAPTER 1 PROTOZOA OF THE INTESTINAL TRACT

□ 1.1 - Giardia lamblia □ 1.2 - Entamoeba histolytica □ 1.3 - Cryptosporidium spp. CHAPTER 2 PROTOZOA OF THE CNS

□ 2.1 - Toxoplasma gondii □ 2.2 - Trypanosoma brucei □ 2.3 - Naegleria fowleri CHAPTER 3 PROTOZOA OF THE BLOOD

□ □ □ □ □

3.1 - Trypanosoma cruzi 3.2 - Babesia spp. 3.3 - Plasmodium Part 1 3.4 - Plasmodium Part 2: Treatment and PPX 3.5 - Leishmania braziliensis & donovani

CHAPTER 4 PROTOZOA - OTHER TISSUE □

4.1 - Trichomonas Vaginalis

CHAPTER 5 HELMINTHS - NEMATODES

Page 4 of 5

SKETCHY MICRO

□ 5.1 - Enterobius vermicularis, Ancylostoma duodenale, Necator americanus, Ascaris lumbricoides, Strongyloides stercoralis, Trichinella spiralis (intestinal nematodes) □ 5.2 - Dracunculus medinensis, Wuchereria bancrofti, Onchocerca volvulus, Toxocara canis, Loa loa (tissue nematodes) CHAPTER 6 HELMINTHS - TREMATODES AND CESTODES

□ 6.1 - Cestodes □ 6.2 - Trematodes

Page 5 of 5

SKETCHY PHARM

I.

Autonomic Drugs

CHAPTER 1 PARASYMPATHETIC

□ 1.1 - Cholinomimetics □ 1.2 - Acetylcholinesterase Inhibitors □ 1.3 - Muscarinic antagonists CHAPTER 2 SYMPATHETIC

□ □ □ □

II.

2.1 - Sympathomimetics 2.2 - Indirect sympathomimetics 2.3 - Alpha drugs 2.4 - Beta blockers

Cardiovascular & Renal

CHAPTER 1 HEART FAILURE DRUGS □ 1.1 - Digoxin, milrinone, nesiritide □ 1.2 - ACE inhibitors, ARBs, Aliskiren CHAPTER 2 DIURETICS □ □ □ □

2.1 - Acetazolamide, mannitol 2.2 - Loop diuretics 2.3 - Thiazides 2.4 - K+ sparing diuretics

CHAPTER 3 ANTIHYPERTENSIVES □ 3.1 - Calcium channel blockers □ 3.2 - Primary hypertension & hypertensive emergency CHAPTER 4 ANTIARRHYTHMICS □ □ □ □ □

4.1 - Class I A-C 4.2 - Class II 4.3 - Class III 4.4 - Class IV 4.5 - Class V

Page 1 of 5

SKETCHY PHARM

III. Blood & Inflammation CHAPTER 1 ANTICOAGULANTS & THROMBOLYTICS □ □ □ □

1.1 - Heparin, LMWH, fondaparinux, direct thrombin inhibitors, Xa inhibitors 1.2 - Warfarin 1.3 - Antiplatelet agents 1.4 - Thrombolytics

CHAPTER 2 DYSLIPIDEMIA DRUGS □ 2.1 - Statins □ 2.2 - Cholestyramine, ezetimibe □ 2.3 - Fibrates, niacin CHAPTER 3 ANTI-INFLAMMATORY □ 3.1 - NSAIDs □ 3.2 - Gout drugs

IV. Smooth Muscle CHAPTER 1 VASOACTIVE □ 1.1 - Nitrates □ 1.2 - Triptans & migraine □ 1.3 - Prostaglandins, prostacyclin, bosentan, PDE5 inhibitors CHAPTER 2 ALLERGY & PULMONARY □ 2.1 - Antihistamines □ 2.2 - Asthma therapy

V.

GI & Endocrine

CHAPTER 1 GI □ 1.1 - Antiemetic Agents □ 1.2 - H2 receptor blockers, PPIs □ 1.3 - Laxatives & antidiarrheal agents

Page 2 of 5

SKETCHY PHARM

CHAPTER 2 DIABETES □ 2.1 - Insulin, sulfonylureas, meglitinides, GLP-1 agonists, DPP-4 inhibitors □ 2.2 - Metformin, thiazolidinediones, pramlintide, SGLT2 inhibitors CHAPTER 3 THYROID, PARATHYROID & ADRENAL □ □ □ □

3.1 - Propylthiouracil, methimazole, levothyroxine 3.2 - Bisphosphonates, raloxifene, denosumab, calcitonin 3.3 - Teriparatide, vitamin D, cinacalcet, sevelamer 3.4 - Glucocorticoids

CHAPTER 4 HYPOTHALAMIC & PITUITARY □ 4.1 - Growth hormone, mecasermin, octreotide, pegvisomant □ 4.2 - ADH, DDAVP, ADH receptor antagonists

VI. Neuro/Psych CHAPTER 1 SEDATIVE-HYPNOTICS □ 1.1 - Benzodiazepines, flumazenil □ 1.2 - Nonbenzodiazepine hypnotics, melatonin, ramelteon □ 1.3 - Barbiturates CHAPTER 2 ANESTHETICS & ANALGESICS □ 2.1 - Propofol, etomidate, ketamine □ 2.2 - Inhaled anesthetics, dantrolene □ 2.3 - Opiates, naloxone, naltrexone CHAPTER 3 ANTIDEPRESSANTS & ANXIOLYTICS □ □ □ □

3.1 - SSRIs, SNRIs, cyproheptadine 3.2 - Tricyclic antidepressants 3.3 - MAO inhibitors 3.4 - Bupropion, mirtazapine, trazodone

CHAPTER 4 MOOD STABILIZERS & ANTIEPILEPTIC DRUGS □ □ □ □

4.1 - Lithium 4.2 - Valproate, topiramate, lamotrigine, levetiracetam 4.3 - Carbamazepine, phenytoin, gabapentin, tiagabine, vigabatrin 4.4 – Ethosuximide

Page 3 of 5

SKETCHY PHARM

CHAPTER 5 ANTIPSYCHOTICS & PARKINSON'S □ 5.1 - First generation antipsychotics □ 5.2 - Second generation antipsychotics □ 5.3 - Levodopa/carbidopa, entacapone, tolcapone, selegiline, ropinirole, pramipexole, amantadine

VII. Antimicrobials CHAPTER 1 CELL WALL AND MEMBRANE ACTIVE ANTIBIOTICS □ □ □ □ □ □ □

1.1 - Penicillin 1.2 - Nafcillin, Oxacillin, Methicillin & Dicloxacillin 1.3 - Ampicillin, Amoxicillin, Piperacillin, Ticarcillin 1.4 - Cephalosporins 1.5 - Monobactams & Carbapenems 1.6 - Vancomycin 1.7 - Daptomycin

CHAPTER 2 INHIBITORS OF BACTERIAL PROTEIN SYNTHESIS □ □ □ □ □ □

2.1 - Tetracyclines 2.2 - Macrolides 2.4 - Clindamycin 2.5 - Chloramphenicol 2.6 - Linezolid 2.7 - Aminoglycosides

CHAPTER 3 ANTIMYCOBACTERIALS □ 3.1 - Tuberculosis Drugs □ 3.2 - Leprosy drugs CHAPTER 4 OTHER ANTIBIOTICS □ 4.1 - Trimethoprim/Sulfamethoxazole □ 4.2 - Fluoroquinolones □ 4.3 - Metronidazole

Page 4 of 5

SKETCHY PHARM

CHAPTER 5 ANTIFUNGALS □ 5.1 - Amphotericin, flucytosine □ 5.2 - Azoles □ 5.3 - Griseofulvin, Terbinafine, Echinocandins CHAPTER 6 ANTIVIRALS: HIV □ □ □ □

6.1 - NRTIs 6.2 - NNRTIs 6.3 - Protease inhibitors 6.4 - Maraviroc, fusion inhibitors, integrase inhibitors

CHAPTER 7 ANTIVIRALS: OTHER □ 7.1 - Acyclovir, valacyclovir, famciclovir □ 7.2 - Ganciclovir, valganciclovir, foscarnet, cidofovir

VIII. Antineoplastics CHAPTER 1 ANTIMETABOLITES □ 1.1 - Methotrexate, leucovorin, 5-fluorouracil, hydroxyurea □ 1.2 - Azathioprine, 6-mercaptopurine, mycophenolate mofetil □ 1.3 - Cladribine, cytarabine, gemcitabine CHAPTER 2 DNA & CELLULAR DIVISION □ 2.1 - Cyclophosphamide, ifosfamide, busulifan, nitrosoureas (carmustine, lomustine, streptozocin) □ 2.2 - Cisplatin, carboplatin, oxaliplatin, amifostine □ 2.3 - Bleomycin, doxorubicin, daunorubicin, actinomycin D □ 2.4 - Etoposide, teniposide, topotecan, irinotecan □ 2.5 - Vincristine, vinblastine, paclitaxel CHAPTER 3 KINASE INHIBITORS & MONOCLONAL ANTIBODIES □ 3.1 - Imatinib, erlotinib, sorafenib, sunitinib, vemurafenib □ 3.2 - Rituximab, cetuximab, bevacizumab, alemtuzumab, trastuzumab CHAPTER 4 IMMUNOLOGY □ 4.1 - Interferon α, β, γ

Page 5 of 5

SKETCHY PATH

I. Cardiac CHAPTER 1 ISCHEMIC HEART DISEASE □ □ □

1.1 - Myocardial Response To Ischemia 1.2 - Stable Angina, Vasospastic Angina, & Acute Coronary Syndromes (UA, NSTEMI, STEMI) 1.3 - Acute Myocardial Infarction & Post-MI Timeline

CHAPTER 2 HEART FAILURE □ □

2.1 - Congestive Heart Failure - Pathophysiology 2.2 - Congestive Heart Failure - Clinical Manifestations

CHAPTER 3 MYOCARDIAL & PERICARDIAL DISORDERS □ □ □ □

3.1 - Dilated and Restrictive Cardiomyopathy 3.2 - Hypertrophic Cardiomyopathy 3.3 - Myocarditis 3.4 - Pericarditis & Constrictive Pericarditis

CHAPTER 4 VALVULAR DISORDERS □ □ □

4.1 - Mitral Stenosis, Acute Rheumatic Fever & Rheumatic Heart Disease 4.2 - Mitral Valve Regurgitation and Prolapse 4.3 - Aortic Stenosis and Regurgitation

CHAPTER 5 CONGENITAL HEART DISEASE □ □

5.1 - Left-to-Right Shunts 5.2 - Right-to-Left Shunts

II. Vascular CHAPTER 1 ATHEROSCLEROSIS □ □

1.1 - Atherosclerosis: Pathophysiology 1.2 - Peripheral Artery Disease

CHAPTER 2 HYPERTENSION □ □ □

2.1 - Hypertension 2.2 - Aortic Aneurysm 2.3 - Aortic Dissection

CHAPTER 3 VASCULITIDES □ □

3.1 - Large & Medium Vessel Vasculitides 3.2 - Small Vessel Vasculitides

Page 1 of 7

SKETCHY PATH

III. Pulmonary CHAPTER 1 OBSTRUCTIVE LUNG DISEASE □ □

1.1 - COPD & Emphysema 1.2 - Asthma & Bronchiectasis

CHAPTER 2 RESTRICTIVE LUNG DISEASE □ □ □ □

2.1 - Restrictive Lung Disease (Overview) 2.2 - Idiopathic Pulmonary Fibrosis 2.3 - Pneumoconioses 2.4 - Sarcoidosis & Berylliosis

CHAPTER 3 ACUTE LUNG DISORDERS □ □ □

3.1 - Pneumothorax 3.2 - Acute Respiratory Distress Syndrome (ARDS) 3.3 - Deep Vein Thrombosis & Pulmonary Embolism

CHAPTER 4 LUNG CANCER □

4.1 - Lung Carcinoma

IV. Renal CHAPTER 1 ACUTE KIDNEY INJURY □ □ □

1.1 - Renal Function Tests & Acute Kidney Injury (AKI) 1.2 - Acute Tubular Necrosis (ATN) 1.3 - Tubulointerstitial Nephritis

CHAPTER 2 GLOMERULOPATHY □ □

2.1 - Nephrotic Syndrome 2.2 - Nephritic Syndrome

CHAPTER 3 CONGENITAL & CHRONIC KIDNEY DISEASE □ □

3.1 - Congenital & Cystic Kidney Disease 3.2 - Chronic Kidney Disease (CKD)

CHAPTER 4 URINARY TRACT OBSTRUCTION □ □ □

4.1 - Hydronephrosis & Urinary Tract Obstruction 4.2 - Calcium Oxalate Stones & Calcium Phosphate Stones 4.3 - Magnesium Ammonium Phosphate (MAP) Stones, Uric Acid Stones, & Cystine Stones

CHAPTER 5 RENAL CANCER Page 2 of 7

SKETCHY PATH □

5.1 - Renal Cell Carcinoma & Nephroblastoma

CHAPTER 6 VOLUME, ELECTROLYTE & ACID/BASE DISORDERS □ □ □ □ □

6.1 - Osmolality & Sodium Disorders 6.2 - Potassium Disorders 6.3 - Calcium Disorders 6.4 - Acid/Base Disorders 6.5 - Renal Tubular Acidosis (RTA)

V. GI CHAPTER 1 ESOPHAGEAL & GASTRIC DISORDERS □ □ □ □

1.1 - Structural Esophageal Disorders & GERD 1.2 - Esophageal Dysmotility & Cancer 1.3 - Acute and Chronic Gastritis & Peptic Ulcer Disease 1.4 - Gastric Dysmotility & Cancer

CHAPTER 2 SMALL BOWEL DISORDERS □ □ □ □

2.1 - Small Bowel Obstruction, Ileus & Hernias 2.2 - Carcinoid Tumor & Small Bowel Neoplasms 2.3 - Intestinal Ischemia & Angiodysplasia 2.4 - Congenital GI Disorders

CHAPTER 3 COLORECTAL & ANAL DISORDERS □ □ □ □

3.1 - Large Bowel & Appendiceal Disorders 3.2 - Crohn's Disease & Ulcerative Colitis 3.3 - Colorectal Polyps & Cancer 3.4 - Anorectal Disorders

VI. Hepatobiliary CHAPTER 1 GALLBLADDER & BILIARY TRACT DISEASE □ □ □

1.1 - Lab Evaluation of Liver Injury & Hyperbilirubinemia 1.2 - Gallbladder & Biliary Tract Disease 1.3 - Autoimmune Biliary Tract Disorders & Cancer

CHAPTER 2 LIVER DISEASE □ □ □

2.1 - Cirrhosis - Pathogenesis & Clinical Manifestations 2.2 - Hereditary Hemochromatosis & Wilson's Disease 2.3 - Alcoholic and Non-alcoholic Fatty Liver Disease Page 3 of 7

SKETCHY PATH □

2.4 - Liver Tumors & Hepatocellular Carcinoma

CHAPTER 3 PANCREATIC DISEASE □ □

3.1 - Acute & Chronic Pancreatitis 3.2 - Pancreatic Cancer & Islet Cell Tumors

VII. Endocrine CHAPTER 1 HYPOTHALAMIC & PITUITARY DISORDERS □ □ □ □

1.1 - Hypothalamic & Pituitary Dysfunction - Etiologies 1.2 - Hypothalamic & Pituitary Dysfunction - Clinical Manifestations 1.3 - Hyperpituitarism 1.4 - Diabetes Insipidus & SIADH

CHAPTER 2 ADRENAL DISORDERS □ □ □ □ □

2.1 - Adrenal Insufficiency 2.2 - Congenital Adrenal Hyperplasia (CAH) 2.3 - Adrenocortical Hyperfunction: Hyperaldosteronism & Hypercortisolism 2.4 - Cushing's Syndrome 2.5 - Pheochromocytoma & Neuroblastoma

CHAPTER 3 DIABETES □ □ □

3.1 - Diabetes Mellitus: Pathogenesis & Acute Clinical Manifestations 3.2 - Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 3.3 - Diabetes Mellitus: Chronic Complications

CHAPTER 4 THYROID & PARATHYROID □ □ □ □ □ □ □

4.1 - Hypothyroidism: Overview & Hashimoto's Thyroiditis 4.2 - Hypothyroidism: Other Causes 4.3 - Hyperthyroidism: Overview & Graves' Disease 4.4 - Thyroid Nodules & Cancer 4.5 - Parathyroid Gland Disorders 4.6 - Multiple Endocrine Neoplasia (MEN)

VIII. Reproductive & GU CHAPTER 1 UTERINE & VULVOVAGINAL DISORDERS □ □ □

1.1 - Abnormal Uterine Bleeding (AUB) & Endometriosis 1.2 - Cervical Neoplasia 1.3 - Vulvar & Vaginal Lesions Page 4 of 7

SKETCHY PATH CHAPTER 2 REPRODUCTIVE HORMONES & OVARIAN DISORDERS □ □ □ □

2.1 - Reproductive Hormones Overview & Polycystic Ovary Syndrome (PCOS) 2.2 - Amenorrhea 2.3 - Ovarian Cysts & Epithelial Ovarian Cancer 2.4 - Ovarian Neoplasms (Germ Cell & Sex Cord-Stromal Tumors)

CHAPTER 3 GESTATIONAL DISORDERS □ □ □

3.1 - Hydatidiform Mole & Choriocarcinoma 3.2 - Gestational Disorders 3.3 - Polyhydramnios & Oligohydramnios

CHAPTER 4 BREAST □ □

4.1 - Benign Breast Disorders 4.2 - Breast Cancer

CHAPTER 5 MALE GU □ □ □

5.1 - Testicular Disorders & Cancer 5.2 - Benign Prostatic Hyperplasia (BPH) & Prostate Cancer 5.3 - Bladder Cancer & Penile Disorders

IX. Blood & Coagulation CHAPTER 1 MICROCYTIC ANEMIAS □ □

1.1 - Microcytic Anemia: Overview & Thalassemias 1.2 - Iron Deficiency Anemia & Anemia of Chronic Disease

CHAPTER 2 NORMOCYTIC & MACROCYTIC ANEMIAS □ □ □ □ □

2.1 - Extravascular Hemolysis: Overview & RBC Membrane Defects 2.2 - Intravascular Hemolysis: Overiew & Paroxysmal Nocturnal Hemoglobinuria (PNH) 2.3 - G6PD Deficiency & Autoimmune Hemolytic Anemia (AIHA) 2.4 - Sickle Cell Disease 2.5 - Megaloblastic Anemia: Folate Deficiency & Vitamin B12 Deficiency

CHAPTER 3 COAGULOPATHIES & PLATELET DISORDERS □ □ □ □ □

3.1 - Quantitative Platelet Disorders 3.2 - Qualitative Platelet Disorders 3.3 - Inherited Coagulation Defects 3.4 - Acquired Coagulation Defects 3.5 - Acquired & Inherited Thrombosis Syndromes

Page 5 of 7

SKETCHY PATH

X. Myeloid & Lymphoid CHAPTER 1 MYELOID DISORDERS □ □ □

1.1 - Myeloproliferative Neoplasms & Myelodysplastic Syndromes 1.2 - Acute Myeloid Leukemia (AML) & Chronic Myeloid Leukemia (CML) 1.3 - Polycythemia

CHAPTER 2 LYMPHOID & PLASMA CELL DISORDERS □ □ □ □

2.1 - Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Hairy Cell Leukemia & Adult T-cell Leukemia 2.2 - Hodgkin Lymphoma 2.3 - Non-Hodgkin Lymphoma 2.4 - Plasma Cell Neoplasms

XI. Immunology CHAPTER 1 AUTOIMMUNE & AMYLOIDOSIS □ □ □ □

1.1 - Autoimmune Disease: Overview & Systemic Lupus Erythematosus (SLE) 1.2 - Sjogren's Syndrome, Systemic Sclerosis & Mixed Connective Tissue Disease 1.3 - Polymyositis & Dermatomyositis 1.4 - Amyloidosis

CHAPTER 2 IMMUNODEFICIENCY □ □ □ □

2.1 - B-Cell Disorders & DiGeorge Syndrome 2.2 - Combined B & T-Cell Disorders 2.3 - Complement System Disorders 2.4 - Phagocytic Cell Disorders

XII. Musculoskeletal & Derm CHAPTER 1 BONE □ □ □ □ □

1.1 - Osteoporosis & Paget Disease of Bone 1.2 - Osteomalacia & Rickets 1.3 - Benign Bone Tumors 1.4 - Malignant Bone Tumors 1.5 - Congenital Bone Disorders: Osteogenesis Imperfecta, Achondroplasia & Osteopetrosis

CHAPTER 2 JOINT □

2.1 - Osteoarthritis Page 6 of 7

SKETCHY PATH □ □

2.2 - Rheumatoid Arthritis 2.3 - Gout & Pseudogout

CHAPTER 3 MUSCLE □ □